FGF19 promotes progression of prostate cancer
The Prostate2015Vol. 75(10), pp. 1092–1101
Citations Over TimeTop 10% of 2015 papers
Hirotaka Nagamatsu, Jun Teishima, Keisuke Goto, Hiroyuki Shikuma, Hiroyuki Kitano, Koichi Shoji, Shogo Inoue, Akio Matsubara
Abstract
FGF19 might be associated with biochemical recurrence after radical prostatectomy by promoting cell proliferation and epithelial-mesenchymal transition of PCa.
Related Papers
- → miR-21 as an Independent Biochemical Recurrence Predictor and Potential Therapeutic Target for Prostate Cancer(2012)137 cited
- → Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer(2022)12 cited
- → Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy(2023)5 cited
- → Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer(2009)31 cited
- → Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer(2008)13 cited